Ticker Symbol: RLAY
Relay Therapeutics Inc
$35.39 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001812364
Company Profile
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 399 Binney Street
Website: relaytx.com
CEO: Sanjiv K. Patel
Tags:
- Health Technology
- Pharmaceuticals: Major
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $7.74
Change:
-$0.17
(
-2.15%)
Days Range: $7.26 - $8.15
Beta: 1.32
52wk. High: $23.18
52wk. Low: $6.66
Ytd. Change -50.34%
50 Day Moving Average: $8.65
200 Day Moving Average: $11.12
Shares Outstanding: 122133716
Valuation
Market Cap: 94.5B
PE Ratio: -2.67
EPS (TTM): -2.9
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A